A second-generation TKI should always be used as initial therapy for CML

Research output: Contribution to journalArticle

3 Scopus citations
Original languageEnglish (US)
Pages (from-to)3653-3655
Number of pages3
JournalBlood Advances
Volume2
Issue number24
DOIs
StatePublished - Dec 26 2018

ASJC Scopus subject areas

  • Hematology

Cite this